Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-A tool in analysing receptor specific events

Journal of Immunological Methods

Volumn 331, Issue 1-2, 2008, Pages 50-58

  Fu, Huamei ^a   Karlsson, Jennie ^a   Björkman, Lena ^a   Stenfeldt, Anna Lena ^a   Karlsson, Anna ^a   Bylund, Johan ^a   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

fMLF; FPR FPRL1; Human neutrophils; Superoxide production; WKYMVM

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

CYCLOOXYGENASE INHIBITORS; HL-60 CELLS; HUMANS; NEUTROPHILS; OLIGOPEPTIDES; PIROXICAM; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SODIUM DODECYL SULFATE; SUPEROXIDES;

EID: 39149110602     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.11.005     Document Type: Article

References (44)

1. Ali H., Richardson R.M., Haribabu B., and Snyderman R. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274 (1999) 6027
2. Almkvist J., Faldt J., Dahlgren C., Leffler H., and Karlsson A. Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect. Immun. 69 (2001) 832
3. Almkvist J., Dahlgren C., Leffler H., and Karlsson A. Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe. Exp. Cell Res. 298 (2004) 74
4. Andersson T., Dahlgren C., Lew P.D., and Stendahl O. Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J. Clin. Invest. 79 (1987) 1226
5. Axelsson L.G., Nilsson G., and Bjorksten B. Statistical aspects of cell motility determinations with a modified chemotaxis assembly for multiwell filter assays. J. Immunol. Methods 46 (1981) 251
6. Boyum A., Lovhaug D., Tresland L., and Nordlie E.M. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 34 (1991) 697
7. Bylund J., Karlsson A., Boulay F., and Dahlgren C. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70 (2002) 2908
8. Bylund J., Pellme S., Fu H., Mellqvist U.H., Hellstrand K., Karlsson A., and Dahlgren C. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biol. 5 (2004) 21
9. Christophe T., Karlsson A., Dugave C., Rabiet M.J., Boulay F., and Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276 (2001) 21585
10. Christopher M.J., and Link D.C. Regulation of neutrophil homeostasis. Curr. Opin. Hematol. 14 (2007) 3
11. Colli S., Colombo S., Tremoli E., Stragliotto E., and Nicosia S. Effects of tenoxicam on superoxide anion formation, beta-glucuronidase release and fMLP binding in human neutrophils: comparison with other NSAIDs. Pharmacol. Res. 23 (1991) 367
12. Dahlgren C., and Stendahl O. Effect of in vitro preincubation of polymorphonuclear leukocytes on formylmethionyl-leucyl-phenylalanine-induced chemiluminescence. Infect. Immun. 37 (1982) 34
13. Dahlgren C., and Stendahl O. Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect. Immun. 39 (1983) 736
14. Dahlgren C., and Karlsson A. Respiratory burst in human neutrophils. J. Immunol. Methods 232 (1999) 3
15. Dahlgren C., Christophe T., Boulay F., Madianos P.N., Rabiet M.J., and Karlsson A. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95 (2000) 1810
16. Dixon W.J. Ratios involving extreme values. Ann. Math. Stat. 22 (1951) 68
17. Edwards B.S., Bologa C., Young S.M., Balakin K.V., Prossnitz E.R., Savchuck N.P., Sklar L.A., and Oprea T.I. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol. Pharmacol. 68 (2005) 1301
18. Follin P., Briheim G., Sandstedt S., and Dahlgren C. Human neutrophil chemiluminescence and f-Meth-Leu-Phe receptor exposure in bacterial infections. Apmis 97 (1989) 585
19. Follin P., Wymann M.P., Dewald B., Ceska M., and Dahlgren C. Human neutrophil migration into skin chambers is associated with production of NAP-1/IL8 and C5a. Eur. J. Haematol. 47 (1991) 71
20. Fu H., Bjorkman L., Janmey P., Karlsson A., Karlsson J., Movitz C., and Dahlgren C. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol. 5 (2004) 50
21. Fu H., Bylund J., Karlsson A., Pellme S., and Dahlgren C. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. Immunology 112 (2004) 201
22. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79 (2006) 247
23. Haas P.J., de Haas C.J., Kleibeuker W., Poppelier M.J., van Kessel K.P., Kruijtzer J.A., Liskamp R.M., and van Strijp J.A. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J. Immunol. 173 (2004) 5704
24. He R., Sang H., and Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101 (2003) 1572
25. Heit B., Tavener S., Raharjo E., and Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159 (2002) 91
26. Jones S.A., Wolf M., Qin S., Mackay C.R., and Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6682
27. Karlsson A., Markfjall M., Stromberg N., and Dahlgren C. Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect. Immun. 63 (1995) 4606
28. Le Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 23 (2002) 541
29. Lee M.S., Yoo S.A., Cho C.S., Suh P.G., Kim W.U., and Ryu S.H. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 177 (2006) 5585
30. Liu L., Harbecke O., Elwing H., Follin P., Karlsson A., and Dahlgren C. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response. J. Immunol. 160 (1998) 2463
31. Lundqvist H., and Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 20 (1996) 785
32. Marcenaro E., Della Chiesa M., Dondero A., Ferranti B., and Moretta A. It's only innate immunity but I like it. Adv. Exp. Med. Biol. 590 (2007) 89
33. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Evanoff H.L., Strieter R.M., and Kunkel S.L. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164 (2000) 2738
34. Miller A.F., and Falke J.J. Chemotaxis receptors and signaling. Adv. Protein Chem. 68 (2004) 393
35. Neal T.M., Vissers M.C., and Winterbourn C.C. Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine. Biochem. Pharmacol. 36 (1987) 2511
36. Nigorikawa K., Okamura N., and Hazeki O. The effect of anionic amphiphiles on the recruitment of Rac in neutrophils. J. Biochem. (Tokyo) 136 (2004) 463
37. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., and Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50 (2004) 1788
38. Prat C., Bestebroer J., de Haas C.J., van Strijp J.A., and van Kessel K.P. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J. Immunol. 177 (2006) 8017
39. Riesselman M., Miettinen H.M., Gripentrog J.M., Mumey B., Dratz E.A., Stie J., Taylor R.M., and Jesaitis A.J. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2. J. Immunol. 179 (2007) 2520
40. Sengelov H., Boulay F., Kjeldsen L., and Borregaard N. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299 Pt 2 (1994) 473
41. Stenfeldt A.L., Karlsson J., Wenneras C., Bylund J., Fu H., and Dahlgren C. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Biochem. Pharmacol. 74 (2007) 1050
42. Teufelhofer O., Weiss R.M., Parzefall W., Schulte-Hermann R., Micksche M., Berger W., and Elbling L. Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxide. Toxicol. Sci. 76 (2003) 376
43. Wright A.J., Higginbottom A., Philippe D., Upadhyay A., Bagby S., Read R.C., Monk P.N., and Partridge L.J. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response. Mol. Immunol. 44 (2007) 2507
44. Ye R.D., and Boulay F. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39 (1997) 221